A Certified Reference Material
Features
  • This product is qualified as a Certified Reference Material (CRM) that has been manufactured and tested to meet ISO/IEC 17025 and ISO 17034 international standards
  • This CRM has been characterized by metrologically valid procedures and may be used as a quantitative analytical reference standard
  • Certificate of analysis provides the certified property values and the associated uncertainties, including a statement of metrological traceability for the certified values
  • Possession of a DEA Controlled Substance registration is not necessary nor is a DEA 222 form required to purchase this product
  • Bulk material is available for qualified institutions; please contact our sales department for pricing
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Etodesnitazene (CRM)

A 1 mg/ml solution in methanol

Item No. 43092

Exempt Product (US & Canada)
Safety Data Sheet (SDS) (PDF)
Synonyms
Synonyms
  • Desnitroetonitazene
  • Etazene
  • Etazone
Technical Information
Formal Name
2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazole-1-ethanamine
CAS Number
14030-76-3
Molecular Formula
C22H29N3O
Formula Weight
351.5
Formulation
A 1 mg/ml solution in methanol
SMILES
CCN(CC)CCN1C2=CC=CC=C2N=C1CC3=CC=C(OCC)C=C3
InChi Code
InChI=1S/C22H29N3O/c1-4-24(5-2)15-16-25-21-10-8-7-9-20(21)23-22(25)17-18-11-13-19(14-12-18)26-6-3/h7-14H,4-6,15-17H2,1-3H3
InChi Key
BMLPNUNXHUGDOI-UHFFFAOYSA-N
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.
Canada Exempt Notification
This product is registered as a Canada Test Kit - no additional Health Canada import paperwork or permits required.
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $171

    Add
    Cayman Chemical
    Forensic Lab Guide Wall Posters

    Discover our collection of drug identification, naming, and metabolism posters for your lab. We offer all of our posters at no cost to help support the forensic community.

    REQUEST YOURS
    Product Description

    Etodesnitazene (CRM) (Item No. 43092) is a certified reference material categorized as an opioid.1 Etodesnitazene has been found in parcels seized by law enforcement.2 Etodesnitazene is regulated as a Schedule I compound in the United States. Etodesnitazene (CRM) (Item No. 43092) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Vandeputte, M.M., Van Uytfanghe, K., Layle, N.K., et al. Synthesis, chemical characterization, and µ-opioid receptor activity assessment of the emerging group of "nitazene" 2-benzylbenzimidazole synthetic opioids. ACS Chem. Neurosci. 12(7), 1241-1251 (2021).

    2. Siczek, M., Zawadzki, M., Siczek, M., et al. Etazene (N,N‑diethyl‑2‑{[(4‑ethoxyphenyl)methyl]‑1H‑benzimidazol‑1‑yl}‑ethan‑1‑amine (dihydrochloride)): A novel benzimidazole opioid NPS identifed in seized material: Crystal structure and spectroscopic characterization. Forensic Toxicol. 39(1), 146–155 (2021).

    Product Citations

    Leonard, A.C., Lenert-Mondou, C., Chayer, R., et al. Computational design of dynamic biosensors for emerging synthetic opioids. BioRxiv (2025).